Abortion Pill Mifepristone Will No Longer Require In-Person Pick Up, US FDA Concludes
Executive Summary
REMS modification implemented for the duration of the pandemic will become permanent, the agency determines in response to lawsuit. FDA adds a requirement that pharmacies dispensing the drug be certified.
You may also be interested in...
New Attack Against FDA’s Mifepristone Approval Targets Potential Water Contamination
Students for Life of America requests that FDA revoke approval of mifepristone and REMS changes, claiming the agency failed to determine the medication abortion drug would not pollute waterways. The group’s fourth citizen petition follows similar claim that the agency failed to comply with the Endangered Species Act.
House FY2024 FDA Appropriation Bill Cuts Funding
Tobacco rules limiting nicotine and banning menthol in cigarettes also would be defunded in the bill.
House FY 2024 Approps Bill Nixes US FDA Mifepristone REMS Changes, Cuts Funding
Tobacco rules limiting nicotine and banning menthol in cigarettes also would be defunded in the bill.